This prospective study investigated the relationship between insulin resistance assessed using the homeostatic model assessment of insulin resistance (HoMA-iR) and the prognosis of acute pancreatitis (AP). A total of 269 patients with AP were recruited in this study. HOMA-IR scores were calculated using fasting insulin and plasma glucose levels. patients were then categorized into the non-insulin-resistant group (HoMA-iR <2.5) and the insulin-resistant group (HOMA-IR ≥2.5). We performed multivariable logistic regression analysis to investigate the independent association between IR assessed using HOMA-IR and the severity of AP. We also conducted receiver operating characteristic analysis to investigate the predictive ability of HOMA-IR for severe AP. The proportion of patients with severe AP (according to the Atlanta classification) and the percentage of ICU admissions and mortality were higher in patients with insulin resistance than in those without insulin resistance. the area under the curve (AUC) of HOMA-IR for predicting severe AP was 0.719 (95% CI 0.59-0.85, P = 0.003). This value was not significantly different from the AUCs of other AP scoring systems such as CTSI, Ranson, and BISAP. Insulin resistance was the only independent factor for either ICU admission (OR 5.95, 95% CI 1.95-18.15, P = 0.002) or severe AP (OR 6.72, 95% CI 1.34-33.62, P = 0.020). Our findings suggest that the HOMA-IR score is an independent prognostic factor in patients with acute pancreatitis. This finding indicates that insulin resistance is potentially involved in the mechanism for severe AP.
HoMA-iR for predicting severe acute pancreatitis. We calculated the area under the curves (AUCs) of HOMA-IR, CTSI, Ranson, and BISAP scores for predicting severe AP using receiver operating characteristic Table 3 ). The Ranson score showed the greatest accuracy for prediction of severe AP (AUC = 0.848). The AUC of HOMA-IR for predicting severe AP was 0.719 (95% CI 0.59-0.85, P = 0.003). This value was not notable different from the AUCs of the other scoring systems ( Fig. 1 ). We performed a logistic regression analysis to find risk factors predicting severe AP or ICU admission in patients with AP. IR (HOMA-IR ≥2.5) was the only independent factor for ICU admission (OR 5.95, 95% CI 1.95-18.15, P = 0.002) or severe AP (OR 6.72, 95% CI 1.34-33.62, P = 0.020) ( Tables 4 and 5 ).
Discussion
We demonstrated that insulin resistance assessed using HOMA-IR was significantly associated with AP severity and ICU admission. We found that this significant association between insulin resistance and severe AP was independent of the presence of diabetes, the body mass index, and the levels of inflammation markers. We also demonstrated that the ability of insulin resistance to predict severe AP was as good as other traditional scoring systems for AP. These findings indicate that insulin resistance might be critical to the pathogenesis of AP. An important part of the pathophysiology of AP is inflammation of the pancreatic adipose tissue 13 . MS is a chronic, low-grade inflammatory status characterized by high circulating levels of pro-inflammatory cytokines 16 . Table 3 . Area under the curve for predicting severe acute pancreatitis. AUC, area under the curve; CI, confidence of interval; HOMA-IR, homeostasis model assessment of insulin resistance; CT, computed tomography severity index; BISAP, the Bedside Index for Severity in Acute Pancreatitis.
The inflammatory changes that accompany MS may intensify both the immune and non-immune responses that can trigger and exacerbate AP 21 , which has been confirmed in several investigations showing an increased incidence and severity of AP in patients with MS 13, 14 . The associations among the various components of MS and IR are well documented 11 , and insulin resistance plays an important role in the development of MS 22,23 . However, www.nature.com/scientificreports www.nature.com/scientificreports/ little is known regarding the association between insulin resistance and the prognosis of AP. Therefore, this study aimed to determine the relationship between insulin resistance and the severity of AP. Insulin resistance is defined as a clinical state of decreased sensitivity or responsiveness to insulin 24 . HOMA-IR has a strong linear correlation with glucose clamp estimates of IR and has been widely used in various prospective clinical trials and clinical research studies 25, 26 . A HOMA-IR score ≥2.5 is the accepted cutoff value as an indicator of IR 24, 27 . To date, there has been a single study demonstrating IR as a risk factor for post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis 28 . HOMA-IR was an independent predictor of post-ERCP pancreatitis and was used as a considerable factor in predicting the risk of post-ERCP pancreatitis and in decreasing related morbidity 28 . However, the authors did not demonstrate an association between IR and the severity of the pancreatitis.
Our study illustrates several important and novel findings. First, more females were included in the IR group, and the mean TG and BMI level were higher, compared to the non-IR group. Hypertriglyceridemia is well known in the etiology of AP, and elevated serum TG is independently and proportionally correlated with persistent organ failure, regardless of etiology 5 . Also, obesity induces a low-grade pro-inflammatory state and is linked with the development of complications in cases of AP 6 . The number of cases with severe AP according to the Atlanta classification was higher in the IR group. Also, the number of ICU admissions and the mortality rate were higher in the IR group compared to the non-IR group. Second, our ROC analysis found that for predicting severe AP, the AUC of HOMA-IR was not significantly different from that of other scoring systems. This implies that a simple measurement of serum chemistries at the clinical baseline may be able to reliably replace traditional prognostic indices that require multiple clinical measurements. Third, IR (HOMA-IR ≥2.5) was the only independent factor for ICU admission or severe AP in our study, but other factors, including DM, BMI, and CRP, were not significantly associated with either the development of severe AP or ICU admission. This result strongly supports the prognostic value of HOMA-IR in patients with AP and is also in line with the results of previous studies that failed to demonstrate an association between DM and the severity of AP 29, 30 .
Insulin resistance and hyperglycemia, which are hallmarks of DM, are important factors linked to the susceptibility of diabetics to AP 31 . The existence of links between IR and several pro-inflammatory molecules, such as nuclear factor kB 32 , tumor necrosis factor α 33 , amylin 34 , calcitonin gene-related peptide 35 , leptin 36 and interleukin-6 37 , has been postulated, and these molecules may play a critical role in the pathogenesis of AP in patients with IR. Also, several in vitro studies found that insulin played a protective role against palmitoleic acid-induced AP in rat acinar cells by inhibiting cytosolic calcium overload response 38, 39 and in L-arginine-induced AP rat models by protecting against oxidative stress as well as contributing to acinar cell regeneration 40 . Thus, impaired pancreatic β-cell responsiveness and decreases in circulating insulin caused by pancreatic acinar cell exposure to hyperglycemia, which results in oxidative stress, may play important roles in the susceptibility of diabetics to AP. However, the exact mechanism of the association between IR, DM, and AP has not been fully elucidated. Our findings suggest a possible common pathophysiologic pathway for AP in patients with IR and/or DM. Further investigation into this question may explain the apparently conflicting results regarding a correlation between DM and the incidence and severity of AP presented in past studies.
This study has several limitations. First, the number of patients enrolled in this study was small, and this study was performed in a tertiary care center, which could have resulted in the disproportional inclusion of patients with a severe disease status. Such selection bias might have overestimated the predictive value of HOMA-IR. Second, whether the patients had IR before the diagnosis of AP or IR was a result of AP could not be fully examined. If the patients included in this study would have undergone serum sampling prior to the diagnosis of AP, a more complete explanation as to which is the cause and which is the result may have been available. Third, we did not take into account changes in the HOMA-IR score during treatment, which could have varied according to the progression of AP. Despite these limitations, this study also has a number of strengths. This is the first prospective study investigating the predictive value of HOMA-IR in AP and suggesting HOMA-IR as a possible parameter in improving on previously established severity-scoring systems. Replacing the blood glucose level with HOMA-IR in traditional prognostic scoring systems could improve their performance.
conclusions
HOMA-IR, a surrogate marker of insulin resistance, was the only independent prognostic factor for predicting either severe AP or ICU admission in patients with AP. This finding suggests that insulin resistance might influence the risk of SAP irrespective of the cause of the pancreatitis. Therapy targeted at decreasing insulin resistance may have promising role in improving overall outcomes of SAP. Further investigation is needed to confirm the possible deleterious effect of insulin resistance on AP prognosis and to investigate the underlying biological mechanisms for this association in greater detail.
Methods

patients. This was a prospective study of patients with AP in Yonsei University Wonju College of Medicine
from March 2015 to April 2018. The study protocol was approved by the International Review Board for Human Research (CR315005-002) of Yonsei University Wonju College of Medicine. This study was performed in accordance with relevant guidelines and regulations. Written informed consent was obtained from all patients.
AP was diagnosed based on the presence of two of the following three features 41 : (1) typical abdominal pain, (2) serum amylase and/or lipase ≥3 times the upper normal limit, and (3) radiologic findings. Laboratory tests on peripheral blood samples, such as hemoglobin, hematocrit, white blood cell count, calcium, phosphorus, blood urea nitrogen, creatinine, lactate dehydrogenase, aspartate aminotransferase, C-reactive protein (CRP, normal range <0.5 mg/dL), and arterial blood gas analysis, were performed at the time of admission. An abdominal computed tomography (CT) scan was performed on all patients upon admission to differentiate AP from other diseases. Once AP was diagnosed, the levels of fasting insulin, glucose, and triglyceride (TG) were verified. The HOMA-IR score was calculated as × Glucose Insulin 405 with glucose in mg/dL, and a HOMA-IR score ≥2.5 was taken as
